Jay Lefton has served on the Ontario Genomics’ Board of Directors since 2006. He has broad experience in public as well as private mergers and acquisitions. His knowledge of both the corporate legal culture and the life sciences sector assists the Board in its oversight of operational and business development. Mr. Lefton is a partner at Fasken Martineau DuMoulin in Toronto, where he is active in corporate and securities law, including public and private financings, mergers, acquisitions and take-over bids, private equity, and strategic alliances, technology transfer and licensing, with an emphasis on technology and life sciences companies. He has served on the Ontario Securities Commission’s Securities Advisory Committee, chaired the Board of Outside Advisors for the University of Toronto’s Rotman School of Business, and been on the adjunct faculty at the Osgoode Hall School of Law (Toronto). He sits on the Board of Governors of the University of Ontario Institute of Technology and on the Board of Directors of the Thunder Bay Regional Health Research Institute. He has previously been a Director of Pathways to Education Canada, the Ontario Neurotrauma Foundation (Toronto), ThinkFirst Foundation of Canada (Toronto), and the Board of the University of Toronto’s Innovations Foundation. He is a past Chair of the Cell Therapy Program Advisory Board of Princess Margaret Hospital (Toronto). Mr. Lefton earned his B.Comm. (Hons) and LL.B. from the University of Toronto, and in 1983 joined the Ontario Bar.

 Cell Therapy Program Advisory